| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.008 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |